# 42 CFR 456.705 Prospective drug review.

42 CFR 456.705 Prospective drug review., “Prospective drug review”, is a CFR section of [42 CFR Part 456, Subpart K—Drug Use Review (DUR) Program and Electronic Claims Management System for Outpatient Drug Claims](https://ontology.bommaritollc.com/id/01a0f0b4-29bb-77ca-b0a9-627faed24335); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3>

Within: [Title 42—Public Health](https://ontology.bommaritollc.com/id/01a0f0b4-250a-76eb-a6f4-ef896ca65429) › [42 CFR Chapter IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f0b4-26ab-75ee-82a3-d67c7d7493e9) › [42 CFR Chapter IV, Subchapter C—MEDICAL ASSISTANCE PROGRAMS](https://ontology.bommaritollc.com/id/01a0f0b4-2893-7639-a8af-94dd05194691) › [42 CFR Part 456—Utilization control](https://ontology.bommaritollc.com/id/01a0f0b4-2c9d-7201-beec-ac1245f6677b) › [42 CFR Part 456, Subpart K—Drug Use Review (DUR) Program and Electronic Claims Management System for Outpatient Drug Claims](https://ontology.bommaritollc.com/id/01a0f0b4-29bb-77ca-b0a9-627faed24335)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 42 CFR 456.705](https://ontology.bommaritollc.com/id/01a0f0b4-501f-71cc-8788-bc83daf6b1f7)
- `eli:cites`:
  - [42 CFR 456.702 Definitions.](https://ontology.bommaritollc.com/id/01a0f0b4-5014-72d3-8bcc-d0cd2b7b0006)
  - [42 CFR 456.703 Drug use review program.](https://ontology.bommaritollc.com/id/01a0f0b4-5019-7011-92d7-08b3d4849d8d)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title42-vol1](https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e86140b0d17e)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0b4-6edd-70a9-8280-fe85b25c93a3)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d1-98fa-72dc-b9c3-7da403f164f4)
  - [evidence from https://www.govinfo.gov/link/cfr/42/456?sectionnum=705&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-ff7a-75ef-ab0d-323ef7f6d1f5)
- `schema:isPartOf`: [42 CFR Part 456, Subpart K—Drug Use Review (DUR) Program and Electronic Claims Management System for Outpatient Drug Claims](https://ontology.bommaritollc.com/id/01a0f0b4-29bb-77ca-b0a9-627faed24335)
- `schema:legislationIdentifier`: 42 CFR 456.705
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Prospective drug review
- `schema:url`: [https://www.govinfo.gov/link/cfr/42/456?sectionnum=705&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/42/456?sectionnum=705&year=mostrecent&link-type=details)
- `skos:prefLabel`: 42 CFR 456.705 Prospective drug review.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/42/456?sectionnum=705&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title42-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (3; `eli:cites`):
  - [42 CFR 456.709 Retrospective drug use review.](https://ontology.bommaritollc.com/id/01a0f0b4-501f-71cc-8788-bc8567ac65ab)
  - [42 CFR 456.711 Educational program.](https://ontology.bommaritollc.com/id/01a0f0b4-5020-777f-ab27-275a9a7a090f)
  - [42 CFR 456.722 Electronic claims management system.](https://ontology.bommaritollc.com/id/01a0f0b4-5034-7199-be21-37e1a5bd0072)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3)
Cite as: 42 CFR 456.705 Prospective drug review.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f0b4-501a-71de-b8d6-e862252d28f3
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
